Journal article icon

Journal article

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial

Abstract:

Objective: To study the immunogenicity and reactogenicity of a combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine (Hib-MenC-TT) when administered as a booster dose in combination with a measles, mumps and rubella vaccine (MMR). Design: A phase 3 open randomised controlled trial. Setting: One centre in Oxford, Uk and nine centres in Poland. Subjects: 12-15-month-old healthy children. Interventions: In the primary state of the study 5...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1136/adc.2007.136036

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Research group:
Oxford Vaccine Group
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Research group:
Oxford Vaccine Group
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Research group:
Oxford Vaccine Group
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Research group:
Oxford Vaccine Group
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Centre for Statistics in Medicine
Role:
Author
Expand authors...
More from this funder
Funding agency for:
Pollard, A
"GlaxoSmithKline Biologicals, Rixensart, Belgium" More from this funder
Publisher:
BMJ Publishing Group Publisher's website
Journal:
Archives of Disease in Childhood Journal website
Volume:
93
Issue:
11
Pages:
963-970
Publication date:
2008-11-01
DOI:
EISSN:
14682044
Language:
English
Subjects:
UUID:
uuid:180f47fd-9277-4b1d-a7e5-d13f038df2da
Local pid:
ora:3181
Deposit date:
2009-12-21

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP